PR Hub

Intermune Inc.

InterMune Announces Positive Opinion for Approval of Esbriet(TM) (Pirfenidone) in European Union


BRISBANE, California, December 17, 2010 - -- Esbriet to be the first medicine approved for IPF patients in the EU -- InterMune, Inc.
MORE..

InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet(TM) (Pirfenidone) in Europe


BRISBANE, California, December 17, 2010 - -- Conference call and webcast today at 8:30 a.m.
MORE..
Older News
S M T W T F S
29 30 31 1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
Copyright© 2010 The Gaea Times